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Abstract 
Globally there are more than half a million new cases of head and neck 
cancer each year 1,2.  More than 90% of head and neck tumours are head 
and neck squamous cell carcinomas (HNSCCs) which originate in the lip/oral 
cavity, nasopharynx, oropharynx, hypopharynx and the larynx 1,3.   
 
HNSCCs are inadequately diagnosed and as a result many head and neck 
cancer patients are diagnosed at the advanced stages of the disease 4. The 
lack of biomarkers for HNSCC has resulted in this poor diagnosis of the 
cancer. Furthermore, a limited understanding of the molecular biology of the 
cancer has led to few treatment options. The future of HNSCC diagnosis and 
treatment can lie in the small non-coding RNAs called miRNAs. miRNAs 
function as gene regulators and have been implicated in the development 
and progression of various cancers 5-8. In HNSCC, two miRNAs miR-21 and 
miR-499 have been found to be upregulated in tumours compared to normal 
tissues 9. Furthermore, these miRNAs both regulate the tumour suppressor 
gene Programmed Cell Death 4 (PDCD4). PDCD4 has been found to be 
involved in oncogenic pathways including apoptosis, proliferation, 
angiogenesis and invasion 10,11. PDCD4 is also downregulated in many 
HNSCC tumours 12-14. This thesis endeavoured to determine the role of miR-
21 and miR-499 in HNSCC through their regulation of PDCD4.  
 
The first aim was to study the co-regulation of PDCD4 by miR-21 and miR-
499. When genes are co-regulated by miRNAs this can lead to heavy 
regulation of the genes 15. This is essential for genes critical to cancer 
initiation and progression 15. Currently there are limited studies examining the 
various modes of regulation miRNAs can use to simultaneously regulate a 
single gene at its 3´ untranslated region (3´UTR). In this project, site mutants 
for miR-21 and miR-499 at the 3´UTR of PDCD4 were created and ligated to 
luciferase reporter vectors. Using luciferase assays it was revealed that miR-
21 and miR-499 regulate the 3´UTR independently of each other. However, 
miR-21 does aid miR-499 interactions with the PDCD4 3´UTR. Furthermore, 
the last two miR-499 sites are regulated in a co-dependent manner and 
mutating either site completely abolishes regulation of PDCD4 by miR-499. 
This is the first study detailing the regulatory dynamics of PDCD4. 
 
The co-regulation of PDCD4 by miR-21 and miR-499 has an extra layer of 
complexity in that the miRNAs also have a regulatory relationship with each 
other. Overexpression of miR-21 was found to endogenously upregulate 
miR-499 expression in cells. There are few studies in the literature on miRNA 
mediated regulation of another miRNA. These studies show that miRNA 
mediated regulation usually occurs when a miRNA(s) has a binding site in the 
primary transcript of another miRNA or at the promoter region of the mature 
miRNA 16-18.  Further research into miR-21’s upregulation of miR-499, found 
that the regulation was not reciprocal as overexpression of miR-499 did not 
affect miR-21 levels. A few models were designed and tested to investigate 
how miR-21 was able to regulate miR-499. Primary levels of miR-499 were 
unchanged by miR-21 overexpression. Thus regulation of miR-499 by miR-21 
occurred post-transcription. The stability of miR-499 was measured when de 
novo synthesis of miRNAs was switched off. miR-499 was found like other 
miRNAs to degrade over 24 hours. However, if miR-21 was overexpressed in 
cells then miR-499 levels were stabilised. It was thought that perhaps miR-21 
is able to stabilise miR-499 through target-mediated miRNA protection 
(TMMP). In this model the half-life of a miRNA can be increased by its 
interactions with a target mRNA 19,20. It is predicted that through a gene like 
PDCD4 miR-21 is able to encourage miR-499 interactions with the gene. 
Perhaps miR-21 binding removes obtrusive secondary structure at the miR-
499 binding sites on the 3´UTR. This allows miR-499 to interact with the gene 
thus protecting it from degradation. 
 
A few studies have found that a single miRNA is able to alter the expression 
of multiple miRNAs 21,22. However, the mechanism behind this or even if this 
is a common occurrence with miRNAs in general is still yet to be understood. 
Therefore, the regulation of miR-499 by miR-21 was extended genome-wide 
to determine if other miRNAs were also affected by miR-21 overexpression. 
Affymetrix arrays revealed that not only were many miRNAs upregulated by 
miR-21 overexpression but also downregulated. Furthermore, miR-499 
overexpression could also differentially regulate other miRNAs. The miRNAs 
that were most upregulated by miR-21 were found to have targets that could 
potentially be co-targeted by several of these miRNAs. miR-21 and miR-499 
also had genes that they could potentially co-target together. Therefore, 
perhaps miRNAs that are regulated by other miRNAs are involved in 
regulating similar genes leading to an enhanced or differential regulation of 
these genes.  
 
Finally, the function of miR-21 and miR-499 in HNSCCs were examined. miR-
21 is involved in certain oncogenic pathways in HNSCCs 23,24, but no studies 
have investigated miR-499’s role. Considering that miRNAs are at the 
forefront of gene dysregulation during cancer initiation and development 25-28, 
it is worth understanding how they are able to affect cancerous processes. 
This is useful for the identification of new biomarkers for HNSCC but also for 
the design of miRNA based therapeutics.  
 
Using live cell imaging and scratch assays, it was found that miR-21 and 
miR-499 were able to promote migration in HNSCCs. It is predicted that this 
promoted migration most likely occurs through the downregulation of the 
tumour suppressor genes PDCD4, SRY (Sex Determining Region Y) Box 6 
and Forkhead Box Protein 04 (FOXO4). These genes have been shown in 
other cancers to be directly involved in migration 29-31.  
 
This thesis explores in depth the regulation of the tumour suppressor gene 
PDCD4 by miR-21 and miR-499 in a HNSCC context. It uncovers the type of 
regulation this gene undergoes, the relationship between the two miRNAs 
and other miRNAs and the function of these miRNAs in HNSCC.  Studies 
such as these pave the way for designing new clinical therapeutics by 




Publications and abstracts 
associated with this thesis 
 
Publications arising from this thesis 
P Ajuyah., A Ahadi., J Lu., G Hutvagner., N Tran (2016) The unique co-
regulation of the tumour suppressor gene PDCD4 by miR-21 and miR-499. In 
Preparation. 
 
Abstracts associated with this thesis 
P Ajuyah., G Hutvanger., N Tran (2015) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. ICEI Conference, Shenzhen, 
China. April 18-20. 
 
P Ajuyah., G Hutvanger., N Tran (2014) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. New Horizons Conference. 
The Kolling Institute of Medical Research, Sydney, Australia. November 17-19. 
 
P Ajuyah., G Hutvanger., N Tran (2014) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. JaJRNA Conference. The 
University of Technology, Sydney, Australia. November 2-5. 
 
P Ajuyah., G Hutvanger., N Tran (2014) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. Lorne Genome Conference. 
Mantra Lorne, Australia. February 16-18. 
 
P Ajuyah., G Hutvanger., N Tran (2014) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. RNAUK 2014 Conference. 
Windermere, UK. January 24-26.  
 
P Ajuyah., G Hutvanger., N Tran (2014) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. RNA Silencing Keystone 
Symposia. Seattle, USA. January 31 – February 5. 
 
P Ajuyah., G Hutvanger., N Tran (2013) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. Scientific Research Meeting. 
The Kolling Institute of Medical Research. Sydney, Australia. November 18-20. 
 
P Ajuyah., G Hutvanger., N Tran (2012) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. Scientific Research Meeting. 
The Kolling Institute of Medical Research. Sydney, Australia. November 20-21. 
 
P Ajuyah., G Hutvanger., N Tran (2012) The unique co-regulation of the tumour 
suppressor gene PDCD4 by miR-21 and miR-499. Networks in the Life 
Sciences. 14th International EMBL PhD Symposium. Heidelberg, Germany. 
October 25-27. 
  















actD  actinomycin D 
bp  base pair 
BOT  base of tongue 
CDS  coding sequence 
CMM  cooperative miRNA module 
DC  double transfection control siRNA 
DK  double transfection siAgo2  
DMEM dulbecco’s modified eagle medium 
DMSO dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
dNTPs deoxynucleotides 
ECL  enhanced chemiluminescence 
EMT  epithelial-mesenchymal transition 
FBS  fetal bovine serum 
FOM  floor or mouth 
FOXO4 forkhead box protein 04 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
 HITS-CLIP high-throughput sequencing of RNA isolated by crosslinking          
HHHHHGHJKimmunoprecipitation  
HNSCC head and neck squamous cell carcinoma 
HPV  human papillomavirus 
KD  knock down 
KO  knock out 
LB  luria-bertani 
MAP4K1 mitogen-activated protein kinase kinase kinase kinase 1 
miRNA microRNAs 
ncRNA non-coding RNA 
NEB  new england biolabs 
nt  nucleotide  
oncomiRs oncogenic miRNAs 
ORF  open reading frame 
OSCC  oral squamous cell carcinoma 
PAR-CLIP photoactivatable ribonucleoside–enhanced cross-linking and 
HHHHHGHJKimmunoprecipitation 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PDCD4 programmed cell death 4 
piRNA  piwi-interacting RNAs 
pri-miRNA primary miRNA 
qPCR  quantitative real-time PCR 
RISC  RNA induced silencing complex 
RNA  ribonucleic acid 
RNA pol II RNA polymerase II 
SC  single transfection control siRNA 
SDS  sodium dodecyl sulfate 
SEER  surveillance, epidemiology and end results 
shRNA short hairpin RNA  
siAgo2 ago2 specific targeting siRNA 
siRNA  short interfering RNA 
SK  single transfection siAgo2  
SNP  single nucleotide polymorphism 
SOX6  SRY (sex determining region Y) box 6 
TMMP target-mediated miRNA protection  
UTR  untranslated region 
WT  wild type 
  
